Search Results

Search

Ethics Talk: Unblinding COVID-19 Vaccine Trials

Submitted by Audiey.Kao@ama… on

In this video and audio edition of Ethics Talk, journal editor in chief, Dr Audiey Kao, talks with Dr Steven Goodman about the ethical and scientific implications of unblinding COVID-19 vaccine trials.

Click here to read the transcript.

Steven Goodman, MD, MHS, PhD is Associate Dean of Clinical and Translational Research and Professor of Medicine and of Epidemiology and Population Health at Stanford School of Medicine.

Video

 

Audio

 

Conflict of Interest Disclosure
Interviewee had no conflicts of interest to disclose.

Viewpoints expressed are those of interview participants and do not necessarily reflect the views and policies of the AMA.

Header Image image Issue Legacies of the Holocaust in Health Care CME Off

Ethics Talk: Equity and Intellectual Property Protection of COVID Vaccines

Submitted by Audiey.Kao@ama… on

In this video and audio edition of Ethics Talk, journal editor in chief, Dr Audiey Kao, talks with Prof Ana Santos Rutschman about the impact of intellectual property regimes on domestic and global responses to the COVID-19 pandemic.

Click here to read the transcript. 

Ana Santos Rutschman, SJD is an assistant professor of law at the Saint Louis University School of Law.

Video

Recorded on April 28, 2021

 

Audio

 

Conflict of Interest Disclosure
Interviewee had no conflicts of interest to disclose.

Viewpoints expressed are those of interview participants and do not necessarily reflect the views and policies of the AMA.

Header Image image Issue Ending the HIV Epidemic CME Off

Ethics Talk: Could Trusting Science Mean Not Trusting Some FDA Decisions?

Submitted by Audiey.Kao@ama… on

In this video and audio edition of Ethics Talk, journal editor in chief, Dr Audiey Kao, talks with Dr Caleb Alexander about the US Food and Drug Administration's controversial decision to approve aducanumab for the treatment of Alzheimer's Disease.

Click here to read the transcript.

G. Caleb Alexander, MD, MS is professor of epidemiology and medicine at Johns Hopkins Bloomberg School of Public Health.

Video

Recorded on June 22, 2021

 

Neurology Patient Care

Audio

 

Conflict of Interest Disclosure

Dr Alexander is past chair and current member of FDA's Peripheral and Central Nervous System Drugs Advisory Committee. He is a co-founding principal and equity holder in Monument Analytics, a health care consultancy whose clients include the life sciences industry as well as plaintiffs in opioid litigation. He was also a member of OptumRx's National Pharmacy and Therapeutics Committee.

Viewpoints expressed are those of interview participants and do not necessarily reflect the views and policies of the AMA.

Header Image image Issue Visibility and Measurability in Health Care Off
History of Medicine
Feb 2021

How Ancestral Trauma Informs Patients’ Health Decision Making

Tina K. Sacks, PhD, Katie Savin, MSW, and Quenette L. Walton, PhD, LCSW
Would you question health decisions made by a 37-year old Black woman whose great-grandfather died in the US Public Health Service Syphilis Study at Tuskegee?
AMA J Ethics. 2021;23(2):E183-188. doi: 10.1001/amajethics.2021.183.
State of the Art and Science
Mar 2021

Piloting and Scaling a Good Health Equity Evidence Base From Big Data

Stephen Lockhart, MD, PhD
One health system’s development and validation of inequity measures across patient groups demonstrates an approach that could be nationally scalable.
AMA J Ethics. 2021;23(3):E252-257. doi: 10.1001/amajethics.2021.252.
Original Research
Mar 2021

African American Nurses’ Perspectives on Genomic Medicine Research

Rachele M. Hendricks-Sturrup, DHSc, MSc, MA, Lauren M. Edgar, MSN Ed, RN, Tracey Johnson-Glover, MSN, RN, and Christine Y. Lu, PhD, MSc
Recent popular interest in Henrietta Lacks has prompted interest in better engaging AA nurses and communities.
AMA J Ethics. 2021;23(3):E240-251. doi: 10.1001/amajethics.2021.240.
Medicine and Society
Oct 2020

Holding Space for All of Us

Julie E. Lucero, PhD, MPH and Yvette Roubideaux, MD, MPH
Concepts of “governance,” “trust,” and “culture” can help strengthen research partnerships, honor tribal sovereign authority, counter histories of opportunism, and recognize alternative ways of knowing.
AMA J Ethics. 2020;22(10):E882-887. doi: 10.1001/amajethics.2020.882.
Original Research
Oct 2018

Produce Rx Programs for Diet-Based Chronic Disease Prevention

Haley Swartz, MPP
Produce prescription programs can expand patient's food choices and provide financial incentives to change consumption behaviors. If these programs are not linked to established government assistance programs, however, growers could be at risks for bearing the cost.
AMA J Ethics. 2018;20(10):E960-973. doi: 10.1001/amajethics.2018.960
Policy Forum
Oct 2018

What Lies Behind the Transition From Plant-Based to Animal Protein?

Adam Drewnowski, PhD and Jean-Pierre Poulain, PhD
Sociocultural and economic factors drive transition from plant-based to animal-based protein sources in rapidly developing and urbanizing countries of South Asia and Southeast Asia. Better understanding the health impact of this transition requires integrating epidemiological and social science research methods.
AMA J Ethics. 2018;20(10):E987-993. doi: 10.1001/amajethics.2018.987.